CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for YSP Southeast Asia Holding Bhd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

YSP Southeast Asia Holding Bhd
16th Floor, Plaza VADS
No. 1, Jalan Tun Mohd Fuad
Phone: +60 377276390p:+60 377276390 KUALA LUMPUR, 60000  Malaysia Ticker: YSPSAHYSPSAH
Business Summary
Y.S.P. Southeast Asia Holding Berhad is a Malaysia-based pharmaceutical company. The Company provides a range of pharmaceutical, over-the-counter (OTC), veterinary and aquatic products. The Company's segments include Manufacturing, Trading and Investment holding. The Manufacturing segment is engaged in the manufacturing of pharmaceutical products. The Trading segment is involved in the import, export and trading of various kinds of pharmaceutical, traditional herbal and veterinary products. The Company is engaged in investment holding and provision of management services. Its subsidiaries include Y.S.P. (Cambodia) Pte. Ltd., which provides management services in respect of product registration, trademark registration and national marketing and trading in all kinds of pharmaceutical products, and Alpha Active Industries Sdn. Bhd., which is engaged in the manufacturing of biotechnology products and health products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries
2833 Medicinal chemicals and botanical products
8741 Management services
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Independent Non-Executive Chairman of the Board AnisBin Ahmad 77 3/20/2023 9/16/2002
President, Group Managing Director, Executive Director Fang HsinLee 63 11/17/2003 11/17/2003
Vice President Yen MeeYap 56 1/1/2017 1/1/2017
9 additional Officers and Directors records available in full report.

Business Names
Business Name
PT. YSP Industries Indonesia
PT. Yung Shin Pharmaceutical Indonesia
Sun Ten (Singapore) Private Limited
9 additional Business Names available in full report.

General Information
Number of Employees: 519 (As of 12/31/2005)
Outstanding Shares: 141,488,000 (As of 12/31/2023)
Shareholders: 4,592
Stock Exchange: KUL
Fax Number: +60 377276701


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024